title: "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
authors.forename: Andrea
authors.initials: A
authors.lastname: Messori
authors.forename: Benedetta
authors.initials: B
authors.lastname: Santarlasci
authors.forename: Sabrina
authors.initials: S
authors.lastname: Trippoli
authors.forename: Monica
authors.initials: M
authors.lastname: Vaiani
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics*; D011322:Primary Prevention / Q000191:economics
chemical_list: D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors